An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies
Clinical trial NCT00720798 · COMPLETED
Trial details
- NCT number
- NCT00720798
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2013-04-01
- Enrollment
- 2067
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.